Advertisement

Sleep Disturbance in Cancer Survivors

  • Heather L. McGinty
  • Allison J. Carroll
  • Stacy D. Sanford
Chapter
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

Sleep disturbance is highly prevalent among survivors of cancer across the continuum of care. There are numerous unique factors among survivors that may precipitate and/or perpetuate sleep disturbance, including, but not limited to, cancer diagnosis and treatment. Similar to the general population, sleep disturbance is negatively associated with multiple domains of quality of life, including the emotional and physical well-being of cancer survivors. Moreover, sleep disturbance often co-occurs with other common behavioral symptoms such as fatigue, pain, depression, and cognitive impairment. Routine screening for sleep disturbance is recommended, especially at key transitions in care (e.g., a change in treatment or transition off of treatment). Guidelines for thorough assessment and treatment of sleep disturbance exist; however, research examining sleep in cancer survivors is a growing area of inquiry. The best empirical support to date is for treating insomnia among cancer survivors using cognitive behavioral therapy for insomnia. Additional clinical research is warranted to establish the efficacy of treatment modalities, including pharmacotherapy, for sleep disturbance among cancer survivors.

Keywords

Cancer Sleep disturbance Insomnia Assessment Treatment Quality of life 

References

  1. 1.
    American Cancer Society. Cancer treatment and survivorship facts & figures 2014–2015. Atlanta: American Cancer Society; 2014.Google Scholar
  2. 2.
    Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19(3):895–908.PubMedGoogle Scholar
  3. 3.
    Davidson JR, Feldman-Stewart D, Brennenstuhl S, Ram S. How to provide insomnia interventions to people with cancer: insights from patients. Psychooncology. 2007;16(11):1028–38. doi: 10.1002/pon.1183.CrossRefPubMedGoogle Scholar
  4. 4.
    National Cancer Institute. Sleep Disorders—For Health Professionals (PDQ®). Bethesda, MD: National Cancer Institute; 2015 [updated April 23, 2014; cited May 7, 2015]; Available from: http://cancer.gov/cancertopics/pdq/supportivecare/sleepdisorders/HealthProfessional.
  5. 5.
    Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010;28(2):292–8. doi: 10.1200/jco.2009.22.5011.CrossRefPubMedGoogle Scholar
  6. 6.
    Hugel H, Ellershaw JE, Cook L, Skinner J, Irvine C. The prevalence, key causes and management of insomnia in palliative care patients. J Pain Symptom Manage. 2004;27(4):316–21. doi: 10.1016/j.jpainsymman.2003.09.010.CrossRefPubMedGoogle Scholar
  7. 7.
    Thomas KS, Bower J, Hoyt MA, Sepah S. Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes. Psychooncology. 2010;19(7):767–76. doi: 10.1002/pon.1639.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Savard J, Ivers H, Savard MH, Morin CM. Cancer treatments and their side effects are associated with aggravation of insomnia: results of a longitudinal study. Cancer. 2015;121(10):1703–11. doi: 10.1002/cncr.29244.CrossRefPubMedGoogle Scholar
  9. 9.
    Silberfarb PM, Hauri PJ, Oxman TE, Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol. 1993;11(5):997–1004.PubMedGoogle Scholar
  10. 10.
    Sanford SD, Wagner LI, Beaumont JL, Butt Z, Sweet JJ, Cella D. Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer. Support Care Cancer. 2013;21(4):959–67. doi: 10.1007/s00520-012-1612-7.CrossRefPubMedGoogle Scholar
  11. 11.
    Chen ML, Yu CT, Yang CH. Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy. Lung Cancer. 2008;62(3):391–400. doi: 10.1016/j.lungcan.2008.03.016.CrossRefPubMedGoogle Scholar
  12. 12.
    Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage. 2002;24(5):471–80. doi: 10.1016/S0885-3924(02)00500-6.CrossRefPubMedGoogle Scholar
  13. 13.
    Lis C, Gupta D, Grutsch J. The relationship between insomnia and patient satisfaction with quality of life in cancer. Support Care Cancer. 2008;16(3):261–6. doi: 10.1007/s00520-007-0314-z.CrossRefPubMedGoogle Scholar
  14. 14.
    Taylor LM, Espie CA, White CA. Attentional bias in people with acute versus persistent insomnia secondary to cancer. Behav Sleep Med. 2003;1(4):200–12. doi: 10.1207/S15402010BSM0104_3.CrossRefPubMedGoogle Scholar
  15. 15.
    Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, Dimsdale J, Cohen-Zion M, Fiorentino L. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006;14(3):201–9. doi: 10.1007/s00520-005-0861-0.CrossRefPubMedGoogle Scholar
  16. 16.
    Berger AM, Farr LA, Kuhn BR, Fischer P, Agrawal S. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage. 2007;33(4):398–409. doi: 10.1016/j.jpainsymman.2006.09.022.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24(5):583–90.PubMedGoogle Scholar
  18. 18.
    Fleming L, Gillespie S, Espie CA. The development and impact of insomnia on cancer survivors: a qualitative analysis. Psychooncology. 2010;19(9):991–6. doi: 10.1002/pon.1652.CrossRefPubMedGoogle Scholar
  19. 19.
    Savard J, Simard S, Hervouet S, Ivers H, Lacombe L, Fradet Y. Insomnia in men treated with radical prostatectomy for prostate cancer. Psychooncology. 2005;14(2):147–56. doi: 10.1002/pon.830.CrossRefPubMedGoogle Scholar
  20. 20.
    Van Onselen C, Paul SM, Lee K, Dunn L, Aouizerat BE, West C, Dodd M, Cooper B, Miaskowski C. Trajectories of sleep disturbance and daytime sleepiness in women before and after surgery for breast cancer. J Pain Symptom Manage. 2013;45(2):244–60. doi: 10.1016/j.jpainsymman.2012.02.020.CrossRefPubMedGoogle Scholar
  21. 21.
    Eyigor S, Eyigor C, Uslu R. Assessment of pain, fatigue, sleep and quality of life (QoL) in elderly hospitalized cancer patients. Arch Gerontol Geriatr. 2010;51(3):e57–61. doi: 10.1016/j.archger.2009.11.018.CrossRefPubMedGoogle Scholar
  22. 22.
    Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T. Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol. 2001;80(3):137–43.CrossRefPubMedGoogle Scholar
  23. 23.
    Andrykowski MA, Carpenter JS, Greiner CB, Altmaier EM, Burish TG, Antin JH, Gingrich R, Cordova MJ, Henslee-Downey PJ. Energy level and sleep quality following bone marrow transplantation. Bone Marrow Transplant. 1997;20(8):669–79. doi: 10.1038/sj.bmt.1700949.CrossRefPubMedGoogle Scholar
  24. 24.
    Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, Dimsdale JE, Mills PJ, Parker BA, Sadler GR, Ancoli-Israel S. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 2009;32(9):1155–60.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun. 2012;26(5):706–13. doi: 10.1016/j.bbi.2012.02.001.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Dhruva A, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Dunn LB, Swift PS, Wara W, Miaskowski C. A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J Pain Symptom Manage. 2012;44(2):215–28. doi: 10.1016/j.jpainsymman.2011.08.010.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Kumar RJ, Barqawi A, Crawford ED. Adverse events associated with hormonal therapy for prostate cancer. Rev Urol. 2005;7 Suppl 5:S37–43.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Savard J, Davidson JR, Ivers H, Quesnel C, Rioux D, Dupéré V, Lasnier M, Simard S, Morin CM. The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage. 2004;27(6):513–22. doi: 10.1016/j.jpainsymman.2003.10.013.CrossRefPubMedGoogle Scholar
  29. 29.
    Hanisch LJ, Gehrman PR. Circadian rhythm of hot flashes and activity levels among prostate cancer patients on androgen deprivation therapy. Aging Male. 2011;14(4):243–8. doi: 10.3109/13685538.2011.582528.CrossRefPubMedGoogle Scholar
  30. 30.
    Bardwell WA, Profant J, Casden DR, Dimsdale JE, Ancoli-Israel S, Natarajan L, Rock CL, Pierce JP. The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology. 2008;17(1):9–18.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, Schwartz K, Katz SJ. Symptom experience and quality of life of women following breast cancer treatment. J Womens Health. 2007;16(9):1348–61.CrossRefGoogle Scholar
  32. 32.
    Otte JL, Carpenter JS, Russell KM, Bigatti S, Champion VL. Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manage. 2010;39(3):535–47.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Hoffman AJ, Given BA, von Eye A, Gift AG, Given CW. Relationships among pain, fatigue, insomnia, and gender in persons with lung cancer. Oncol Nurs Forum. 2007;34(4):785–92. doi: 10.1188/07.onf.785-792.CrossRefPubMedGoogle Scholar
  34. 34.
    Gooneratne NS, Dean GE, Rogers AE, Nkwuo JE, Coyne JC, Kaiser LR. Sleep and quality of life in long-term lung cancer survivors. Lung Cancer. 2007;58(3):403–10. doi: 10.1016/j.lungcan.2007.07.011.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Mulrooney DA, Ness KK, Neglia JP, Whitton JA, Green DM, Zeltzer LK, Robison LL, Mertens AC. Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS). Sleep. 2008;31(2):271–81.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Clanton NR, Klosky JL, Li C, Jain N, Srivastava DK, Mulrooney D, Zeltzer L, Stovall M, Robison LL, Krull KR. Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2011;117(11):2559–68.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Palesh OG, Collie K, Batiuchok D, Tilston J, Koopman C, Perlis ML, Butler LD, Carlson R, Spiegel D. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol. 2007;75(1):37–44. doi: 10.1016/j.biopsycho.2006.11.002.CrossRefPubMedGoogle Scholar
  38. 38.
    Miaskowski C, Lee KA. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage. 1999;17(5):320–32.CrossRefPubMedGoogle Scholar
  39. 39.
    Mercadante S, Girelli D, Casuccio A. Sleep disorders in advanced cancer patients: prevalence and factors associated. Support Care Cancer. 2004;12(5):355–9. doi: 10.1007/s00520-004-0623-4.CrossRefPubMedGoogle Scholar
  40. 40.
    Mercadante S, Aielli F, Adile C, Ferrera P, Valle A, Cartoni C, Pizzuto M, Caruselli A, Parsi R, Cortegiani A, Masedu F, Valenti M, Ficorella C, Porzio G. Sleep disturbances in patients with advanced cancer in different palliative care settings. J Pain Symptom Manage. 2015;23(15):410–8.Google Scholar
  41. 41.
    Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541–53.PubMedGoogle Scholar
  42. 42.
    Fiorentino L, Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev. 2006;10(6):419–29. doi: 10.1016/j.smrv.2006.03.005.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Vena C, Parker K, Cunningham M, Clark J, McMillan S. Sleep-wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment. Oncol Nurs Forum. 2004;31(4):735–46. doi: 10.1188/04.onf.735-746.CrossRefPubMedGoogle Scholar
  44. 44.
    Blask DE. Melatonin, sleep disturbance, and cancer risk. Sleep Med Rev. 2009;13(4):257–64. doi: 10.1016/j.smrv.2008.07.007.CrossRefPubMedGoogle Scholar
  45. 45.
    Davis MP, Goforth HW. Long-term and short-term effects of insomnia in cancer and effective interventions. Cancer J. 2014;20(5):330–44. doi: 10.1097/ppo.0000000000000071.CrossRefPubMedGoogle Scholar
  46. 46.
    Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007;8(12):1065–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, Lee K, Miaskowski C, Puntillo K, Rankin S, Taylor D. Advancing the science of symptom management. J Adv Nurs. 2001;33(5):668–76.CrossRefPubMedGoogle Scholar
  48. 48.
    Barsevick AM. The concept of symptom cluster. Semin Oncol Nurs. 2007;23(2):89–98. doi: 10.1016/j.soncn.2007.01.009.CrossRefPubMedGoogle Scholar
  49. 49.
    Donovan KA, Jacobsen PB. Fatigue, depression, and insomnia: evidence for a symptom cluster in cancer. Semin Oncol Nurs. 2007;23(2):127–35. doi: 10.1016/j.soncn.2007.01.004.CrossRefPubMedGoogle Scholar
  50. 50.
    Sanford SD, Beaumont JL, Butt Z, Sweet JJ, Cella D, Wagner LI. Prospective longitudinal evaluation of a symptom cluster in breast cancer. J Pain Symptom Manage. 2014;47(4):721–30. doi: 10.1016/j.jpainsymman.2013.05.010.CrossRefPubMedGoogle Scholar
  51. 51.
    Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008;26(6):971–82. doi: 10.1200/jco.2007.10.7805.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Thornton LM, Andersen BL, Blakely WP. The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. Health Psychol. 2010;29(3):333–7.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Irwin MR. Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes. Curr Psychiatry Rep. 2013;15(11):404. doi: 10.1007/s11920-013-0404-1.CrossRefPubMedGoogle Scholar
  54. 54.
    Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 2011;29(26):3517–22.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Howell D, Oliver TK, Keller-Olaman S, Davidson J, Garland S, Samuels C, Savard J, Harris C, Aubin M, Olson K, Sussman J, Macfarlane J, Taylor C. A Pan-Canadian practice guideline: prevention, screening, assessment, and treatment of sleep disturbances in adults with cancer. Support Care Cancer. 2013;21(10):2695–706. doi: 10.1007/s00520-013-1823-6.CrossRefPubMedGoogle Scholar
  56. 56.
    NCCN. Survivorship. National Comprehensive Cancer Network; 2015 [updated 2015; cited May 7, 2015]; Version 1.2015: Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#supportive.
  57. 57.
    Savard MH, Savard J, Simard S, Ivers H. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology. 2005;14(6):429–41. doi: 10.1002/pon.860.CrossRefPubMedGoogle Scholar
  58. 58.
    Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000;88(9):2164–71.CrossRefPubMedGoogle Scholar
  59. 59.
    Buysse DJ, Yu L, Moul DE, Germain A, Stover A, Dodds NE, Johnston KL, Shablesky-Cade MA, Pilkonis PA. Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep. 2010;33(6):781–92.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst. 2008;100(16):1155–66. doi: 10.1093/jnci/djn250.CrossRefPubMedGoogle Scholar
  61. 61.
    NCCN. Cancer-related fatigue: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2003;1(3):308–31.Google Scholar
  62. 62.
    Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004;291(16):2013–6.CrossRefPubMedGoogle Scholar
  63. 63.
    Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, Khajehdehi A, Shapiro CM. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108(5):812–21. doi: 10.1097/ALN.0b013e31816d83e4.CrossRefPubMedGoogle Scholar
  64. 64.
    Hogl B, Kiechl S, Willeit J, Saletu M, Frauscher B, Seppi K, Muller J, Rungger G, Gasperi A, Wenning G, Poewe W. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology. 2005;64(11):1920–4.CrossRefPubMedGoogle Scholar
  65. 65.
    Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.PubMedPubMedCentralGoogle Scholar
  66. 66.
    Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, Carlson LE, Garland SN. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev. 2016;27:20–28. doi: 10.1016/j.smrv.2015.07.001.
  67. 67.
    Garland SN, Johnson JA, Savard J, Gehrman P, Perlis M, Carlson L, Campbell T. Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients. Neuropsychiatr Dis Treat. 2014;10:1113–24. doi: 10.2147/ndt.s47790.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol. 2005;23(25):6083–96. doi: 10.1200/jco.2005.09.548.CrossRefPubMedGoogle Scholar
  69. 69.
    Savard J, Ivers H, Savard MH, Morin CM. Is a video-based cognitive behavioral therapy for insomnia as efficacious as a professionally administered treatment in breast cancer? Results of a randomized controlled trial. Sleep. 2014;37(8):1305–14. doi: 10.5665/sleep.3918.PubMedPubMedCentralGoogle Scholar
  70. 70.
    Ritterband LM, Bailey ET, Thorndike FP, Lord HR, Farrell-Carnahan L, Baum LD. Initial evaluation of an Internet intervention to improve the sleep of cancer survivors with insomnia. Psychooncology. 2012;21(7):695–705. doi: 10.1002/pon.1969.CrossRefPubMedGoogle Scholar
  71. 71.
    Tremblay V, Savard J, Ivers H. Predictors of the effect of cognitive behavioral therapy for chronic insomnia comorbid with breast cancer. J Consult Clin Psychol. 2009;77(4):742–50. doi: 10.1037/a0015492.CrossRefPubMedGoogle Scholar
  72. 72.
    Berger AM, Kuhn BR, Farr LA, Von Essen SG, Chamberlain J, Lynch JC, Agrawal S. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J Clin Oncol. 2009;27(35):6033–40. doi: 10.1200/jco.2008.20.8306.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS. Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol. 2014;32(5):449–57. doi: 10.1200/jco.2012.47.7265.CrossRefPubMedGoogle Scholar
  74. 74.
    Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, Snyder C. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012;15(8).Google Scholar
  75. 75.
    Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;15(8).Google Scholar
  76. 76.
    Chiu HY, Huang HC, Chen PY, Hou WH, Tsai PS. Walking improves sleep in individuals with cancer: a meta-analysis of randomized, controlled trials. Oncol Nurs Forum. 2015;42(2):E54–62. doi: 10.1188/15.onf.e54-e62.CrossRefPubMedGoogle Scholar
  77. 77.
    Stevinson C, Steed H, Faught W, Tonkin K, Vallance JK, Ladha AB, Schepansky A, Capstick V, Courneya KS. Physical activity in ovarian cancer survivors: associations with fatigue, sleep, and psychosocial functioning. Int J Gynecol Cancer. 2009;19(1):73–8. doi: 10.1111/IGC.0b013e31819902ec.CrossRefPubMedGoogle Scholar
  78. 78.
    Mustian KM, Sprod LK, Janelsins M, Peppone LJ, Palesh OG, Chandwani K, Reddy PS, Melnik MK, Heckler C, Morrow GR. Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol. 2013;31(26):3233–41. doi: 10.1200/jco.2012.43.7707.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Kiecolt-Glaser JK, Bennett JM, Andridge R, Peng J, Shapiro CL, Malarkey WB, Emery CF, Layman R, Mrozek EE, Glaser R. Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32(10):1040–9. doi: 10.1200/jco.2013.51.8860.CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Cohen L, Warneke C, Fouladi RT, Rodriguez MA, Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer. 2004;100(10):2253–60. doi: 10.1002/cncr.20236.CrossRefPubMedGoogle Scholar
  81. 81.
    Felbel S, Meerpohl JJ, Monsef I, Engert A, Skoetz N. Yoga in addition to standard care for patients with haematological malignancies. Cochrane Database Syst Rev. 2014;12(6).Google Scholar
  82. 82.
    Neikrug AB, Rissling M, Trofimenko V, Liu L, Natarajan L, Lawton S, Parker BA, Ancoli-Israel S. Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med. 2012;10(3):202–16. doi: 10.1080/15402002.2011.634940.CrossRefPubMedGoogle Scholar
  83. 83.
    Ancoli-Israel S, Rissling M, Neikrug A, Trofimenko V, Natarajan L, Parker BA, Lawton S, Desan P, Liu L. Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer. Support Care Cancer. 2012;20(6):1211–9. doi: 10.1007/s00520-011-1203-z.CrossRefPubMedGoogle Scholar
  84. 84.
    Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res. 2003;35(1):12–5.CrossRefPubMedGoogle Scholar
  85. 85.
    Sookprasert A, Johns NP, Phunmanee A, Pongthai P, Cheawchanwattana A, Johns J, Konsil J, Plaimee P, Porasuphatana S, Jitpimolmard S. Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial. Anticancer Res. 2014;34(12):7327–37.PubMedGoogle Scholar
  86. 86.
    Jung B, Ahmad N. Melatonin in cancer management: progress and promise. Cancer Res. 2006;66(20):9789–93. doi: 10.1158/0008-5472.can-06-1776.CrossRefPubMedGoogle Scholar
  87. 87.
    National Sleep Foundation. Safe Use of Sleep Aids. 2014 [updated 2014; cited October 2, 2015]; Available from: https://sleepfoundation.org/insomnia/content/safe-use-sleep-aids.
  88. 88.
    Paltiel O, Marzec-Boguslawska A, Soskolne V, Massalha S, Avitzour M, Pfeffer R, Cherny N, Peretz T. Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of life. Qual Life Res. 2004;13(10):1699–706.CrossRefPubMedGoogle Scholar
  89. 89.
    Casault L, Savard J, Ivers H, Savard MH, Simard S. Utilization of hypnotic medication in the context of cancer: predictors and frequency of use. Support Care Cancer. 2012;20(6):1203–10. doi: 10.1007/s00520-011-1199-4.CrossRefPubMedGoogle Scholar
  90. 90.
    Moore TA, Berger AM, Dizona P. Sleep aid use during and following breast cancer adjuvant chemotherapy. Psychooncology. 2011;20(3):321–5. doi: 10.1002/pon.1756.CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    Lee K, Cho M, Miaskowski C, Dodd M. Impaired sleep and rhythms in persons with cancer. Sleep Med Rev. 2004;8(3):199–212. doi: 10.1016/j.smrv.2003.10.001.CrossRefPubMedGoogle Scholar
  92. 92.
    Braun IM, Rao SR, Meyer FL, Fedele G. Patterns of psychiatric medication use among nationally representative long-term cancer survivors and controls. Cancer. 2015;121(1):132–8. doi: 10.1002/cncr.29014.CrossRefPubMedGoogle Scholar
  93. 93.
    Cankurtaran ES, Ozalp E, Soygur H, Akbiyik DI, Turhan L, Alkis N. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine. Support Care Cancer. 2008;16(11):1291–8.CrossRefPubMedGoogle Scholar
  94. 94.
    Palesh OG, Mustian KM, Peppone LJ, Janelsins M, Sprod LK, Kesler S, Innominato PF, Roth T, Manber R, Heckler C, Fiscella K, Morrow GR. Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Sleep Med. 2012;13(9):1184–90. doi: 10.1016/j.sleep.2012.06.001.CrossRefPubMedPubMedCentralGoogle Scholar
  95. 95.
    Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res. 1998;45(1):5–13.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Heather L. McGinty
    • 1
  • Allison J. Carroll
    • 2
  • Stacy D. Sanford
    • 1
    • 3
  1. 1.Department of Medical Social SciencesNorthwestern University Feinberg School of MedicineChicagoUSA
  2. 2.Department of Preventive MedicineNorthwestern University Feinberg School of MedicineChicagoUSA
  3. 3.Department of Psychiatry and Behavioral SciencesNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations